Heart-failure medicines have different jobs
HealthHub’s heart-failure medication table groups medicines by class and action: ACE inhibitors maintain or improve heart function, selected beta-blockers reduce heart rate and workload, diuretics remove excess salt and water, and aldosterone antagonists suppress aldosterone to protect the heart. NICE recommends that people with heart failure with reduced ejection fraction are offered an ACE inhibitor, a beta-blocker, a mineralocorticoid-receptor antagonist and an SGLT2 inhibitor. An ARNI can replace the ACE inhibitor in defined circumstances, for example when symptoms continue despite maximum tolerated doses or when ACE inhibitor intolerance is present. The combination depends on ejection fraction type, symptoms, kidney function, potassium, blood pressure, rhythm, frailty and the person’s response.
Key takeaways
- Diuretic relief and longer-term protection are separate. HealthHub describes diuretics as medicines that remove excess salt and water, while NICE’s four-class combination for reduced ejection fraction targets different pathways.
- Ejection fraction category changes the evidence. SingHealth defines reduced as LVEF below 40% and preserved as LVEF 50% or above; NICE sets different recommendations for reduced, mildly reduced and preserved ejection fraction.
- Monitoring follows the clinical plan. NICE says check renal function and electrolytes before starting an ACE inhibitor, ARNI, ARB or MRA, then 1 to 2 weeks after starting or dose changes, then every 3 to 6 months once the maximum tolerated dose has been established.
Why does the type of heart failure change the medicine plan?
SingHealth separates heart failure into reduced ejection fraction, where the left ventricle does not contract effectively and LVEF is below 40%, and preserved ejection fraction, where contraction is normal but the left ventricle cannot relax and fill properly and LVEF is 50% or above. Its symptoms list includes shortness of breath at rest or on exertion, difficulty breathing when lying flat, waking up breathless at night, swollen ankles, legs or abdomen, sudden weight gain and tiredness. Diagnosis relies on symptoms, physical examination, blood tests, chest X-ray, ECG and echocardiography.
NICE does not assign the same medicine combination to every ejection fraction category. NICE’s recommendation 1.4.1 says people with heart failure with reduced ejection fraction should be offered an ACE inhibitor, a beta-blocker, a mineralocorticoid-receptor antagonist and an SGLT2 inhibitor. If symptoms continue at the maximum tolerated dose of each of those four medicines, NICE says to consider switching the ACE inhibitor to an ARNI. For mildly reduced ejection fraction NICE says to consider the same four classes, while for preserved ejection fraction it says to consider an MRA and an SGLT2 inhibitor.
SingHealth’s classification of heart failure therefore depends on symptoms, examination and heart imaging rather than the ejection fraction number alone.
Which medicines mainly relieve fluid symptoms?
Singapore HealthHub calls diuretics “water pills” and says they remove excess salt and water from the body by increasing urine flow. Loop diuretics such as furosemide can reduce ankle swelling or breathlessness caused by congestion. That visible response may be rapid, but it does not show what the ACE inhibitor, beta-blocker, MRA or SGLT2 inhibitor is doing.
Diuresis is not a universal measure of protection, however. Too little may leave congestion; too much may contribute to dehydration, low blood pressure, kidney dysfunction or electrolyte disturbance. Daily weight and symptom instructions should be individual. Singapore HealthHub’s heart-failure medicine guidance advises following the clinician-provided furosemide plan rather than making an unplanned change.
| Medicine role | Examples in the tenant | Main comparison question |
|---|---|---|
| Relieve congestion | Furosemide | Are fluid symptoms improving without dehydration, kidney or electrolyte problems? |
| Modify renin-angiotensin pathways | Ramipril and related ACE inhibitor/ARB/ARNI options | What do kidney function, potassium, blood pressure, cough or angioedema history allow? |
| Reduce harmful sympathetic drive | Selected agents such as bisoprolol | Is this an evidence-based ingredient/formulation for the heart-failure type, introduced and monitored when clinically stable? |
| Block mineralocorticoid effects | Spironolactone | Are potassium and kidney function suitable and monitored? |
| SGLT2 pathway | Dapagliflozin | What do kidney function, fluid status, infection risk, fasting/acute illness and diabetes status change? |
Why are selected beta blockers used when they slow the heart?
In stable chronic heart failure with an appropriate indication, selected beta blockers reduce harmful long-term sympathetic stimulation and are part of evidence-based treatment. This does not mean every beta blocker is suitable or that a person with acutely worsening congestion should change one without specialist direction.
HealthHub’s heart-failure table puts bisoprolol, carvedilol and metoprolol in the beta-blocker class, describing beta-blockers as medicines that reduce the workload and oxygen demands of the heart and reduce heart rate. NICE says assess heart rhythm, heart rate and conduction abnormalities with a 12-lead ECG before prescribing, and do not offer a beta-blocker to someone with second-degree or third-degree heart block without a pacemaker or with a heart rate below 50 beats per minute. Pulse, blood pressure, conduction, fatigue, wheeze and signs of worsening congestion affect introduction and adjustment. The beta-blocker comparison explains why class membership alone is insufficient.
What do kidney function and potassium connect?
NICE groups ACE inhibitors, ARBs, ARNIs and MRAs because they can all affect renal function and electrolyte levels. NICE recommendation 1.7.3 says measure renal function and electrolytes before starting an ACE inhibitor, ARNI, ARB or MRA. Recommendation 1.7.4 adds 1 to 2 weeks after starting, 1 to 2 weeks after each dose increment, every 3 to 6 months once the maximum tolerated dose is established, and any time renal function may be compromised. If serum creatinine rises by more than 50% or potassium exceeds 5.5 mmol per litre, NICE says follow local guidelines rather than automatically stopping the medicine. A small change is not the same as failure; a large or symptomatic change needs the results, timing, fluid status and other medicines.
HealthHub’s aldosterone antagonist row warns that spironolactone may cause breast tenderness or enlargement, especially in males, may raise potassium and may affect kidney function. It also says to avoid potassium supplements and high-potassium foods and certain salt substitutes as instructed, and to check kidney function with regular blood tests. NSAIDs, dehydration, potassium supplements, salt substitutes and interacting medicines can alter the same balance. A review should include non-prescription painkillers, supplements and traditional medicines rather than only the cardiology list.
Why can an SGLT2 inhibitor appear on a heart-failure list without diabetes?
SGLT2 inhibitors were first used for diabetes, but current heart-failure guidelines include selected agents for heart failure independent of a simple “has diabetes/does not have diabetes” split. That does not make them ordinary diuretics or interchangeable with glucose-lowering medicines.
Monitoring and sick-day questions include kidney function, volume depletion, genital or urinary symptoms and the rare risk of ketoacidosis, which can occur without very high glucose. Fasting, acute illness, surgery and reduced food or fluid intake need clinician-provided instructions. Do not stop or restart from a generic online rule.
What changes the answer?
- Ejection fraction and cause. SingHealth describes reduced ejection fraction as LVEF below 40% and preserved as LVEF 50% or above; NICE makes separate recommendations for mildly reduced and preserved ejection fraction. Valve disease, rhythm problems and coronary disease may require additional treatment.
- Current fluid status. Congestion, dehydration and stable weight do not call for the same diuretic response. HealthHub says frequent urination is the desired effect of diuretics, while worsening breathlessness or weight increase should be reported.
- Kidney function and potassium. These influence ACE inhibitors, ARBs, ARNIs and MRAs at the same time, which is why NICE uses the before-and-after monitoring schedule.
- Blood pressure, pulse and rhythm. Low pressure, bradycardia or conduction disease can limit or change sequencing. NICE says measure blood pressure before and after each dose increment and avoid beta-blockers if the heart rate is below 50 beats per minute or second-degree or third-degree heart block is present without a pacemaker.
- Frailty and other conditions. Diabetes, COPD/asthma, gout, anaemia, infection and cognitive or mobility issues affect monitoring and adherence. NICE says use the person’s medical history, frailty status, prognosis and preferences when choosing medicines and their order.
- Recent hospital treatment. Discharge changes need reconciliation so old packets do not remain in use beside the new regimen.
Which symptoms need urgent assessment?
Contact the heart-failure service promptly for a rapid increase in swelling or weight according to the personal plan, worsening breathlessness with usual activity or lying flat, reduced urine, new confusion, persistent dizziness or a clear decline in function. These can reflect congestion, low output, infection, kidney problems or medicine effects and cannot be separated reliably at home.
Call 995 or go to the Emergency Department immediately for sudden or severe breathlessness, new chest discomfort, fainting, severe giddiness, blue or grey colour, collapse or rapidly worsening symptoms. Do not wait to see whether an extra diuretic helps. A written clinician-provided plan may cover a planned diuretic adjustment for milder signs such as gradual weight gain or ankle swelling.
Bring all packets, the most recent discharge list, weight/symptom record and blood-test results. The heart-failure condition page explains how diagnosis is made; this article is meant to make the different medicine roles visible before a cardiology or pharmacy discussion.
Sources
- NICE: Chronic heart failure in adults: diagnosis and management.
- Singapore HealthHub: Heart Failure - Medication.
- SingHealth: Heart failure: symptoms and treatments.
- Singapore Agency for Care Effectiveness: Sacubitril/valsartan for chronic heart failure with reduced ejection fraction.
- American Heart Association: Medications used to treat heart failure.
